Skip to main navigation Skip to search Skip to main content

Molecular analysis of mixed endometrioid and serous adenocarcinoma of the endometrium

  • Kate Lawrenson
  • , Elham Pakzamir
  • , Biao Liu
  • , Janet M. Lee
  • , Melissa K. Delgado
  • , Kara Duncan
  • , Simon A. Gayther
  • , Song Liu
  • , Lynda Roman
  • , Paulette Mhawech-Fauceglia
  • University of Southern California
  • Roswell Park Cancer Institute

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

Background: The molecular biology and cellular origins of mixed type endometrial carcinomas (MT-ECs) are poorly understood, and a Type II component of 10 percent or less may confer poorer prognoses. Methodology/Principal Findings: We studied 10 cases of MT-EC (containing endometrioid and serous differentiation), 5 pure low-grade endometrioid adenocarcinoma (EAC) and 5 pure uterine serous carcinoma (USC). Endometrioid and serous components of the MT-ECs were macrodissected and the expression of 60 candidate genes compared between MT-EC, pure USC and pure EAC. We found that four genes were differentially expressed when MT-ECs were compared to pure low-grade EAC: CDKN2A (P = 0.006), H19 (P = 0.010), HOMER2 (P = 0.009) and TNNT1 (P = 0.006). Also while we found that even though MT-ECs closely resembled the molecular profiles of pure USCs, they also exhibit lower expression of PAX8 compared to all pure cases combined (P = 0.035). Conclusion: Our data suggest that MT-EC exhibits the closest molecular and epidemiological similarities to pure USC and supports clinical observations that suggest patients with MT-EC should receive the same treatment as patients with pure serous carcinoma. Novel specific markers of MT-EC could be of diagnostic utility and could represent novel therapeutic targets in the future.

Original languageEnglish
Article numbere0130909
JournalPLOS ONE
Volume10
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Dive into the research topics of 'Molecular analysis of mixed endometrioid and serous adenocarcinoma of the endometrium'. Together they form a unique fingerprint.

Cite this